The 2023 presidential candidate for the Labour Party (LP), Peter Obi, has expressed deep concern over the recent announcement by pharmaceutical giant GlaxoSmithKline (GSK) to exit Nigeria.
GSK, which has been operating in the country for over 50 years, disclosed its decision to discontinue the production of prescription drugs and vaccines in Nigeria.
Peter Obi’s Concern and Criticism of Nigeria’s Business Climate
Contribution of Multinational Companies to Human Capital Development
In summary, Peter Obi, the LP’s presidential candidate, expressed his concern over GlaxoSmithKline’s decision to exit Nigeria, attributing it to the challenging business climate and poor economic management.